Skip to main content

Kamada Ltd

KMDA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001567529

In the last 90 days, Kamada Ltd insiders filed 0 open-market purchases and 2 sales; 51 institutions reported holding it in 13F filings for Q2 2026, worth $36.7M in total; ARK Invest is the only superinvestor holding it.

Q1 2026 vs. Q4 2025

How the institutions holding Kamada Ltd changed between Q4 2025 and Q1 2026.

All holders in Q1 2026All holders in Q4 2025

13F holders of KMDA: Q4 2025 compared with Q1 2026
MeasureQ4 2025Q1 2026Change
Holders4643−3
Shares5.37M5.13M−246.2K (−4.6%)
Value$33.7M$38.1M+$4.41M (+13.1%)

New holders (5)

Institutions that held Kamada Ltd at the end of Q1 2026 but not at the end of Q4 2025.

Institutions new to KMDA in Q1 2026
InstitutionSharesValue% of portfolio
ARK Investment Management LLCSuperinvestorARK Invest269,557$2.23M0.02%
Renaissance Group LLC125,901$1.05M0.04%
Wiley Bros.-Aintree Capital, LLC11,781$98.3K0.00%
Trexquant Investment LP10,783$89.9K0.00%
Forum Finance Group S.A.250$2.00K0.00%

Sold out (8)

Institutions that held Kamada Ltd at the end of Q4 2025 and filed for Q1 2026 without it.

Institutions that sold out of KMDA in Q1 2026
InstitutionShares, Q4 2025Value, Q4 2025
Arrowstreet Capital, Limited Partnership116,631$827.1K
Two Sigma Advisers, LP99,700$703.9K
Citadel Advisors LLC68,398$482.9K
SIH Partners, LLLP19,024$134.3K
XTX Topco Ltd14,566$102.8K
City National Bank of Florida10,132$71.5K
Mirae Asset Global Investments Co., Ltd.2,803$19.8K
Daiwa Securities Group Inc.192$1.00K